$LLY INSIGHTS →

lly · earnings · signals · 3 min read · ♡ 8 · ▢ 2 · ↗ 0

Eli Lilly’s ($LLY) olomorasib received FDA Breakthrough Therapy designation for treating advanced KRAS G12C-mutated pancreatic cancer.

· App research preview · Editorial standards

Read the full research in the app

A subscription is required to access the full thread.

Open in the app →